Re-irradiation for high-grade gliomas: Has anything changed?

Area of Science:

• Neuro-oncology
• Radiation Oncology
• Clinical Neurology

Background:

• Management of recurrent or progressive high-grade gliomas presents a significant challenge for neuro-oncology teams.
• Advances in radiation therapy techniques, imaging, and radiobiology have made re-irradiation (re-RT) a viable option for select patients.
• Individualized treatment decisions are crucial, considering relapse patterns, prior treatments, patient status, and quality of life.

Purpose of the Study:

• To review existing studies on re-irradiation (re-RT) as salvage therapy for high-grade gliomas.
• To provide insights for simplifying decision-making in the management of glioma recurrence.
• To aid in designing optimal therapeutic strategies for patients with recurrent high-grade gliomas.

Main Methods:

• Systematic review of published literature on re-irradiation for high-grade gliomas.
• Analysis of studies focusing on patient selection, dosing, fractionation, target volume definition, imaging, and timing.
• Synthesis of evidence to inform clinical practice.

Main Results:

• Re-irradiation (re-RT) is emerging as a key salvage option for recurrent high-grade gliomas.
• Significant questions remain regarding optimal patient selection, treatment parameters, and planning techniques.
• Evidence synthesis aims to clarify these uncertainties.

Conclusions:

• Re-irradiation (re-RT) offers a potential therapeutic strategy for recurrent high-grade gliomas.
• Further research is needed to address unanswered questions regarding optimal re-RT protocols.
• Individualized patient assessment is paramount for successful re-RT implementation.